Abstract:Yiyang Shu, 1 Yuting Shao, 1 Qi Zhou, 2 Lixia Lu, 3 Zhiyue Wang, 1 Li Zhang, 1 Yanlong Bi 1, 4 1 Department of Ophthalmology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China; 2 Exam Center of Tongji University School of Medicine, Shanghai, People's Republic of China; 3 Department of Biochemistry and Molecular Biology, Tongji Eye Institute, Tongji University School of Medicine, Shanghai, People's Republic of China; 4 Tongji Eye Institute, Tongji University School of Medicine, Shanghai, People's Republic of China Correspondence: Yanlong Bi, Email Aim: To explore the trends in the prevalence and disease burden of cataract from 1990 to 2019, evaluate attributable risk factors, and predict trends over the next decade in China and globally. Methods: Data was obtained from Global Burden of Disease Study 2019. We calculated the age-standardized prevalence rate (ASR) and annual percentage change (EAPC) to show the trends of cataract in China and different regions. We calculated and reported the proportion of disability adjusted life years (DALYs) attributable to risk factors by sex in China and different regions. Then, the Bayesian age-period-cohort (BAPC) analysis model was also used to predict the prevalence trends from 2020 to 2030 in China and globally. Results: The ASR increased from 867.09 in 1990 to 991.56 in 2019 per 100,000 with an EAPC of 0.88 in China. The age-standardized DALY rate of females was higher than males. DALY rates were correlated to household air pollution from solid fuels, tobacco, high fasting plasma glucose and high body-mass index. The projective model indicates that the ASR for cataracts will rise to 1101.35× 10 6 for male and 1616.63× 10 6 for female by 2030. Conclusion: The trends from 1990 to 2030 suggested that the burden of cataract remains high in China. Maintaining good lifestyle habits such as switching to clean energy, reducing cigar intake, controlling blood glucose and weight can reduce the risk of cataracts. As aging increases, China should pay more attention to cataract-induced low vision and blindness and develop public policies to reduce the disease burden. Keywords: China, cataract, disease burden, risk factors A cataract is an ophthalmic condition that causes loss of visual quality due to changes in lens transparency and color, 1 and if left untreated, can eventually develop into severe visual impairment or even blindness. Although cataracts can be cured by surgery and then improve vision, as the population grows and ages, the need for cataract surgery and the associated increase in medical costs will place a growing burden on the health care systems and socioeconomic conditions, and the situation allows no delay. In 1999, the World Health Organization (WHO) and the International Agency for the Prevention of Blindness (IAPB) launched the "Vision 2020: global initiative for the elimination of avoidable blindness the right to sight", focusing on avoidable blindness, including cataract. 2 China is the first country in the Western Pacific region to launch. It is one of the countries having the largest number of blind people in the world, with approximately 6.7 million blind people, representing 18% of the world's blind population at the time. 3 The study of epidemiological data on cataracts in China has significant implications for guiding blindness prevention and treatment efforts. Cataract surgery rate (CSR) is the number of cataract surgeries performed per million people per year, and is commonly used internationally as a measure of cataract blindness prevention and treatment and may also reflect demographic, geographic, or socioeconomic differences. The number of cataract surgeries currently varies from country to country. By the end of 2020, the CSR has exceeded 3000, doubling compared to the end of 2015 in China, and the 14th Five-Year Plan for National Eye Health hopes that CSR will reach 3500 by the end of 2025. A study indicated that in 2020, cataracts still remained the main cause of blindness and visual impairment for people aged 50 and older worldwide, especially in developing countries. 4 Digging deeper into the epidemiological information related to cataract are urgently needed to learn the prevalence and trends of cataract and further help us to formulate policies. The 2019 Global Burden of Disease (GBD) study assessed 369 causes of death or injuries and 87 risk factors in 204 countries and territories, and provided a shared database to assess the burden of blindness and vision loss due to cataracts and the differences in prevalence between countries an -Abstract Truncated-

The burden of vision loss due to cataract in China: findings from the Global Burden of Disease Study 2019

Burden Of Vision Loss Associated With Eye Disease In China 1990-2020: Findings From The Global Burden Of Disease Study 2015

Burden of Vision Loss Associated with Eye Disease in China 1990–2020: Findings from the Global Burden of Disease Study 2015

Association of Sex With the Global Burden of Cataract.

Prevalence and causes of vision loss in China from 1990 to 2019: findings from the Global Burden of Disease Study 2019

Socioeconomic Disparity in Global Burden of Cataract: an Analysis for 2013 with Time Trends Since 1990

Changing Trends in the Disease Burden of Cataract and Forecasted Trends in China and Globally from 1990 to 2030

Forecasting And Analyzing The Disease Burden Of Aged Population In China, Based On The 2010 Global Burden Of Disease Study

Changing Trends in the Global Burden of Cataract Over the Past 30 Years: Retrospective Data Analysis of the Global Burden of Disease Study 2019

Global Patterns in Vision Loss Burden Due to Vitamin A Deficiency from 1990 to 2017.

Burden of vision loss due to diabetic retinopathy in China from 1990 to 2017: findings from the global burden of disease study

Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017

Burdens and trends of blindness and vision loss among those aged 55 years and older: A systematic analysis for the Global Burden of Disease Study 2019

Persistence of severe global inequalities in the burden of blindness and vision loss from 1990 to 2019: findings from the Global Burden of Disease Study 2019

Effective cataract surgical coverage in China: results from the China National Eye Health Study (CNEHS)

Global, regional and national burden of Glaucoma: an update analysis from the Global Burden of Disease Study 2019

Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections

Individual-level socioeconomic status and cataract-induced visual disability among older adults in China: the overview and urban-rural difference

Quantifying the impact of disease severity changes on the burden of blindness: A global decomposition analysis

Epidemiologic Studies of Age-Related Cataract

Trend and projection of the prevalence and burden of near vision loss in China and globally from 1990 to 2030: A Bayesian age-period-cohort modeling study